Treatment patterns in women with breast cancer and endocrine therapy-related menopausal symptoms: a cohort study from the United States, United Kingdom, and Germany
Continuation rates with available treatments for menopausal symptoms in women receiving endocrine therapy for breast cancer treatment/prevention are very low. This indicates a clear unmet need for safe, effective, and well-tolerated treatments in this patient population.
Authors
- Ali Kubba (ORCID: https://orcid.org/0000-0001-8693-9964)
- Thomas Römer (ORCID: https://orcid.org/0000-0001-5241-8095)
- Mariam Saadedine
- David Vizcaya (ORCID: https://orcid.org/0000-0003-0248-7636)
- Asieh Golozar (ORCID: https://orcid.org/0000-0002-4243-155X)
- Victoria Banks (ORCID: https://orcid.org/0000-0002-0087-7641)
- Maja Francuski
- Nils Schoof (ORCID: https://orcid.org/0000-0003-0509-9217)
- Martin Lavallee
- Cecile Janssenswillen
- Carina Dinkel-Keuthage
- Carsten Möeller
Institutions
- St Thomas' Hospital (GB)
- George Washington University (US)
- Bayer (Switzerland) (CH)
- St. Thomas Hospital (CA)
- Sant Joan de Déu Research Foundation (ES)
- University Hospital Cologne (DE)
- Bayer (Germany) (DE)
Publication Details
- Journal
- Menopause The Journal of The North American Menopause Society
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1097/gme.0000000000002611
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00